Lupus Patient-Focused Drug Development Site and Survey
Lupus and Allied Diseases Association, the Lupus Foundation of America, and the Lupus Research Alliance have partnered to hold an Externally-Led Lupus Patient-Focused Drug Development (PFDD) Meeting, Lupus: Patient Voices on September 25, 2017 at the College Park Marriott Hotel & Conference Center in Hyattsville, MD near Washington, DC.
They need to get as many people with lupus as possible to complete the survey to gather input from a diverse patient population to inform the FDA and to also drive the content of the meeting. The meeting provides FDA staff an excellent opportunity to hear patient viewpoints on Lupus; including the symptoms and impacts to daily life that are most important to people with Lupus, as well as their perspective on existing and future treatments. This will help inform the agency’s decisions during the drug development and review process.